CANADA LIFE ASSURANCE Co Has $8.52 Million Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

CANADA LIFE ASSURANCE Co cut its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 27.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 913,192 shares of the pharmacy operator's stock after selling 350,206 shares during the period. CANADA LIFE ASSURANCE Co owned 0.11% of Walgreens Boots Alliance worth $8,515,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the stock. Brooklyn Investment Group boosted its holdings in shares of Walgreens Boots Alliance by 21.1% in the 4th quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator's stock valued at $44,000 after buying an additional 830 shares during the period. First Financial Corp IN boosted its stake in Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after acquiring an additional 885 shares during the period. CWA Asset Management Group LLC grew its holdings in shares of Walgreens Boots Alliance by 9.2% during the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator's stock valued at $120,000 after purchasing an additional 1,084 shares during the last quarter. Metis Global Partners LLC raised its position in shares of Walgreens Boots Alliance by 4.9% during the 4th quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator's stock worth $222,000 after purchasing an additional 1,118 shares during the period. Finally, Harbour Investments Inc. lifted its holdings in shares of Walgreens Boots Alliance by 4.3% in the 4th quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator's stock worth $265,000 after purchasing an additional 1,165 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on WBA. Truist Financial dropped their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research report on Friday, January 31st. Evercore ISI lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a research report on Monday, January 13th. Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. StockNews.com began coverage on shares of Walgreens Boots Alliance in a research note on Saturday, April 19th. They issued a "hold" rating on the stock. Finally, Royal Bank of Canada increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a report on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $10.59.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA traded down $0.02 during trading hours on Friday, hitting $11.01. 6,349,910 shares of the stock were exchanged, compared to its average volume of 20,972,640. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $18.83. The company's 50 day moving average is $10.95 and its 200 day moving average is $10.19. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The firm has a market capitalization of $9.52 billion, a P/E ratio of -1.08, a P/E/G ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. During the same quarter in the prior year, the company earned $1.20 EPS. The firm's revenue for the quarter was up 4.1% compared to the same quarter last year. On average, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.